Abstract:Rationale: Neuroblastoma is a common abdominal malignancy in children. The chemoresistant and relapsed cases have poor prognosis. The genetic background and the mechanism of resistance remain unelucidated. Next-generation sequence (NGS) is becoming a popular tool to unravel the genetic background and to guide precision medicine in oncology studies as well as in clinical practice. Patient concerns: Here we report a neuroblastoma case of a boy aged 2 years and 8 months when first diagnosed, with multiple metastatic sites found in both lungs. The metastatic tumors were resistant to chemotherapy and the patient suffered from severe bone marrow suppression. NGS of the whole exon revealed somatic mutations including 9666 single-nucleotide variants (SNVs) from 5148 genes, 55 copy number variations (CNVs), and 140 insertion-deletion variations. The high frequency of SNVs makes it distinguished case. However, no mutation of key tumor driver genes with functional significance was identified. No abnormality was found in nucleic acid synthesis enzymes. No amplification of c-Myc and n-Myc was found by fluorescence in situ hybridization (FISH). Both NGS and immunohistochemistry (IHC) analysis indicated that DNA mismatch repair (MMR) system was intact. Interventions: After initial diagnosis, the patient received combinational chemotherapy, which includes vindesine, an analogue of adriamycin suggested by NGS data, for 4 months. Radical section of the tumor together with the left kidney and the left adrenal gland was performed 5 months after diagnosis. Postsurgical chemotherapy protocols was similar with the previous. Outcomes: The patient died 2 years after initial diagnosis after 8 relapses following combinational chemotherapy. Lessons: This case of neuroblastoma is with pronounced somatic mutations but unidentified driver gene and therapeutic target. AlthoughNGSis a potentially powerful tool to guideprecision medicine, at current stage, its application in the clinic certainly has its limits. The underlying mechanism of the substantially increased SNV number, as well as the malignant behaviors of the tumor, is yet to be revealed.

Correlation Between the Genetic Variants of Base Excision Repair (BER) Pathway Genes and Neuroblastoma Susceptibility in Eastern Chinese Children

Association of Base Excision Repair Gene Polymorphisms with the Response to Chemotherapy in Advanced Non-Small Cell Lung Cancer

A highly malignant case of neuroblastoma with substantial increase of single-nucleotide variants and normal mismatch repair system: A case report.

Genetic Variations of GWAS-Identified Genes and Neuroblastoma Susceptibility: a Replication Study in Southern Chinese Children.

Association of Potentially Functional Variants in the Xpg Gene with Neuroblastoma Risk in A Chinese Population

Lack of Associations Between XPC Gene Polymorphisms and Neuroblastoma Susceptibility in a Chinese Population.

The Association Between GWAS-identified BARD1 Gene SNPs and Neuroblastoma Susceptibility in a Southern Chinese Population

APEX1 Polymorphisms and Neuroblastoma Risk in Chinese Children: A Three-Center Case-Control Study.

Genetic variations in nucleotide excision repair pathway genes and hepatoblastoma susceptibility

Evaluation of GWAS-identified SNPs at 6p22 with Neuroblastoma Susceptibility in a Chinese Population

Nucleotide excision repair gene polymorphisms and hepatoblastoma susceptibility in Eastern Chinese children: A five-center case-control study

Potentially Functional Polymorphisms in the LIN28B Gene Contribute to Neuroblastoma Susceptibility in Chinese Children

Common Variations Within HACE1 Gene and Neuroblastoma Susceptibility in a Southern Chinese Population.

Association of ERCC1 and XPF polymorphisms with pediatric glioma susceptibility

Functional Polymorphisms in BARD1 Association with Neuroblastoma in a Regional Han Chinese Population

Association Between GPC2 Polymorphisms and Neuroblastoma Risk in Chinese Children.

Genomic Analysis-Integrated Whole-Exome Sequencing of Neuroblastomas Identifies Genetic Mutations in Axon Guidance Pathway

LMO1 Gene Polymorphisms Contribute to Decreased Neuroblastoma Susceptibility in a Southern Chinese Population.

LIN28A gene polymorphisms modify neuroblastoma susceptibility: A four-centre case-control study.

Candidate Gene Association Analysis Of Neuroblastoma In Chinese Children Strengthens The Role Of Lmo1

METTL14 Gene Polymorphisms Confer Neuroblastoma Susceptibility: an Eight-Center Case-Control Study